Yasuda Emi, Serata Masaki, Sako Tomoyuki
Yakult Central Institute for Microbiological Research, 1796 Yaho, Kunitachi, Tokyo 186-8650, Japan.
Appl Environ Microbiol. 2008 Aug;74(15):4746-55. doi: 10.1128/AEM.00412-08. Epub 2008 Jun 13.
Although many Lactobacillus strains used as probiotics are believed to modulate host immune responses, the molecular natures of the components of such probiotic microorganisms directly involved in immune modulation process are largely unknown. We aimed to assess the function of polysaccharide moiety of the cell wall of Lactobacillus casei strain Shirota as a possible immune modulator which regulates cytokine production by macrophages. A gene survey of the genome sequence of L. casei Shirota hunted down a unique cluster of 10 genes, most of whose predicted amino acid sequences had similarities to various extents to known proteins involved in biosynthesis of extracellular or capsular polysaccharides from other lactic acid bacteria. Gene knockout mutants of eight genes from this cluster resulted in the loss of reactivity to L. casei Shirota-specific monoclonal antibody and extreme reduction of high-molecular-mass polysaccharides in the cell wall fraction, indicating that at least these genes are involved in biosynthesis of high-molecular-mass cell wall polysaccharides. By adding heat-killed mutant cells to mouse macrophage cell lines or to mouse spleen cells, the production of tumor necrosis factor alpha, interleukin-12 (IL-12), IL-10, and IL-6 was more stimulated than by wild-type cells. In addition, these mutants additively enhanced lipopolysaccharide-induced IL-6 production by RAW 264.7 mouse macrophage-like cells, while wild-type cells significantly suppressed the IL-6 production of RAW 264.7. Collectively, these results indicate that this cluster of genes of L. casei Shirota, which have been named cps1A, cps1B, cps1C, cps1D, cps1E, cps1F, cps1G, and cps1J, determine the synthesis of the high-molecular-mass polysaccharide moiety of the L. casei Shirota cell wall and that this polysaccharide moiety is the relevant immune modulator which may function to reduce excessive immune reactions during the activation of macrophages by L. casei Shirota.
尽管许多用作益生菌的乳酸杆菌菌株被认为可调节宿主免疫反应,但直接参与免疫调节过程的此类益生菌微生物成分的分子性质在很大程度上尚不清楚。我们旨在评估干酪乳杆菌代田株细胞壁多糖部分作为调节巨噬细胞细胞因子产生的潜在免疫调节剂的功能。对干酪乳杆菌代田株基因组序列进行基因调查,发现了一个由10个基因组成的独特基因簇,其大多数预测的氨基酸序列与其他乳酸菌胞外或荚膜多糖生物合成中涉及的已知蛋白质有不同程度的相似性。该基因簇中8个基因的基因敲除突变体导致对干酪乳杆菌代田株特异性单克隆抗体失去反应性,且细胞壁部分中高分子量多糖极度减少,表明至少这些基因参与高分子量细胞壁多糖的生物合成。通过将热灭活的突变体细胞添加到小鼠巨噬细胞系或小鼠脾细胞中,与野生型细胞相比,肿瘤坏死因子α、白细胞介素-12(IL-12)、IL-10和IL-6的产生受到更大刺激。此外,这些突变体可累加增强脂多糖诱导的RAW 264.7小鼠巨噬细胞样细胞产生IL-6,而野生型细胞则显著抑制RAW 264.7的IL-6产生。总体而言,这些结果表明,干酪乳杆菌代田株的这一基因簇(已命名为cps1A、cps1B、cps1C、cps1D、cps1E、cps1F、cps1G和cps1J)决定了干酪乳杆菌代田株细胞壁高分子量多糖部分的合成,且该多糖部分是相关的免疫调节剂,可能在干酪乳杆菌代田株激活巨噬细胞过程中发挥减少过度免疫反应的作用。